125 related articles for article (PubMed ID: 3354733)
21. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
22. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
[TBL] [Abstract][Full Text] [Related]
23. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
24. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
25. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
26. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures.
Cagnacci A; Zanin R; Cannoletta M; Generali M; Caretto S; Volpe A
Fertil Steril; 2007 Dec; 88(6):1603-8. PubMed ID: 17481628
[TBL] [Abstract][Full Text] [Related]
27. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Kuller LH
J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
[No Abstract] [Full Text] [Related]
28. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
Heald A; Selby PL; White A; Gibson JM
Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179
[TBL] [Abstract][Full Text] [Related]
29. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.
Lindheim SR; Presser SC; Ditkoff EC; Vijod MA; Stanczyk FZ; Lobo RA
Fertil Steril; 1993 Oct; 60(4):664-7. PubMed ID: 8405521
[TBL] [Abstract][Full Text] [Related]
30. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
[TBL] [Abstract][Full Text] [Related]
31. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
32. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
33. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause.
Kaplan B; Aschkenazi-Steinberg S; Yogev Y; Nahum R; Sulkes J; Phisher M
Menopause; 2002; 9(5):354-9. PubMed ID: 12218724
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
[TBL] [Abstract][Full Text] [Related]
35. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
Reuben DB; Palla SL; Hu P; Reboussin BA; Crandall C; Herrington DM; Barrett-Connor E; Greendale GA
Am J Med; 2006 Feb; 119(2):167.e1-8. PubMed ID: 16443423
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hormone replacement with a combination estrogen-progestin regimen for five days per week.
Mishell DR; Shoupe D; Moyer DL; Roy S; Page MA
J Reprod Med; 1991 May; 36(5):351-5. PubMed ID: 2061882
[TBL] [Abstract][Full Text] [Related]
37. Estrogen therapies, lipids, and the heart disease prevention controversy.
Knopp RH; Aikawa K; Knopp EA
Curr Cardiol Rep; 2003 Nov; 5(6):477-82. PubMed ID: 14558990
[TBL] [Abstract][Full Text] [Related]
38. Clinical use of progestins in the menopausal patient: dosage and duration.
Gambrell RD
J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
[TBL] [Abstract][Full Text] [Related]
39. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy.
Chlebowski RT; Anderson G; Pettinger M; Lane D; Langer RD; Gilligan MA; Walsh BW; Chen C; McTiernan A;
Arch Intern Med; 2008 Feb; 168(4):370-7; quiz 345. PubMed ID: 18299491
[TBL] [Abstract][Full Text] [Related]
40. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]